Chouia Yassine* and Amran Wafa
Department of Medicine, University of Amar Telidji, Algeria
*Corresponding Author: Chouia Yassine, Department of Medicine, University of Amar Telidji, Algeria.
Received: September 21, 2021; Published: December 09, 2021
Human immunodeficiency virus is (HIV) is a disease responsible for HIV/AIDS. The virus attacks immune cells of the host organism which renders them uncapable of assuring their role of defence, !thus leading to the deficiency of the immune system against other pathologies.
While HIV has gained the interest of a lot of scientists and doctors who trying to cure it, none of the treatments has been approved as having a substantial effect that eliminates the virus from the host’s body. The current medications only allow the immune system to recover partially while the virus could be under suppression. As technologies develop, new ways of treatment that are more effective and efficient than normal medications are starting to catch the attention of both scientists and doctors alike. One of these fast developing technologies is genetic modification technology, using CRISPR CAS9. This paper concerns itself with the possible applications of CRISPR CAS9 in the treatment of HIV/AIDS.
Keywords: Human Immunodeficiency Virus (HIV); CRISPR CAS9; Immune Cells; Immune System
Citation: Chouia Yassine and Amran Wafa. “CRISPER-CAS9 Utilization for HIV/AIDS Treatment". Acta Scientific Medical Sciences 6.1 (2022): 99-108.
Copyright: © 2022 Chouia Yassine and Amran Wafa. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.